‹‹ Go Back

Márcio Augusto Diniz

Cedars-Sinai Medical Center



‹‹ Go Back

Mourad Tighiouart

Cedars-Sinai Medical Center



‹‹ Go Back

André Rogatko

Cedars-Sinai Medical Center



‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

←Back IconGems-Print

263 – Contributed Poster Presentations: Biopharmaceutical Section

Comparison between Discrete and Continuous Doses for EWOC Designs

Sponsor: Biopharmaceutical Section
Keywords: Phase I clinical trial, EWOC, Continuous dose, Discrete dose

Márcio Augusto Diniz

Cedars-Sinai Medical Center

Mourad Tighiouart

Cedars-Sinai Medical Center

André Rogatko

Cedars-Sinai Medical Center

Although there is an extensive statistical literature showing the disadvantages of dichotomizing continuous variables starting with Cox (1957), categorization is a common practice in clinical research which results in substantial loss of information. A large collection of methods in cancer phase I clinical trial design defines dose of a new agent as a discrete variable. A noteworthy exception is the Escalation With Overdose Control (EWOC) design (Babb et al, 1998) where doses can be defined either as continuous or as a grid of discrete doses. A Monte Carlo simulation study was performed to compare the operating characteristics of continuous and discrete dose EWOC designs. Four equally spaced grids with different interval lengths were considered. The loss of information was measured by several operating characteristics more interpretable for clinicians in addition to the usual statistical measures of bias and mean squared error.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2016 CadmiumCD